Joseph Beaulieu
Plus aucun poste en cours
Historique de carrière de Joseph Beaulieu
Anciens postes connus de Joseph Beaulieu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EPIZYME, INC. | Comptroller/Controller/Auditor | 01/07/2018 | 01/02/2023 |
| Treasurer | 01/07/2018 | - | |
Morningstar, Inc. (Research)
 Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Analyst-Equity | 01/05/2009 | 31/08/2011 |
| Directeur de la Recherche - Actions | 01/05/2009 | 31/08/2011 | |
| ABN AMRO Securities (USA), Inc. | Analyst-Equity | 31/10/1999 | 31/10/1999 |
Formation de Joseph Beaulieu
| The University of Chicago | Undergraduate Degree |
| University of Illinois | Graduate Degree |
| Wallace E Carroll School of Management | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Analyst-Equity | 2 |
| Undergraduate Degree | 2 |
| Director of Research - Equity | 1 |
Sectorielle
| Consumer Services | 4 |
| Finance | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Morningstar, Inc. (Research) is the investment research arm of Morningstar, Inc. (NASDAQ: MORN), an American financial services firm headquartered in Chicago, Illinois. The firm was founded by Joseph Mansueto in 1984 and provides independent portfolio information offering star ratings and analysis of managed funds. They also provide economic commentary and asset allocation information based on qualitative research. | Finance |
| ABN AMRO Securities (USA), Inc. | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Joseph Beaulieu
- Expérience
